Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

Fuller House actor Dave Coulier is currently battling stage 3 cancer. Stage 3 cancer is a fairly advanced form of cancer but ...

American Oncology Institute (AOI) in collaboration with Nangia Specialty Hospital in Nagpur, has introduced the advanced Gallium generator marking a new chapter in precision medicine. It will enable ...

Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has ...

It can develop in children at any age, but it's uncommon in children younger than 5. Statistics on survival can be found in Survival Rates for Childhood Non-Hodgkin Lymphoma. Our team is made up of ...

Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called T cells and B cells become ...

X-rays, CT scans, and MRI – you may have had at least one of these tests done during your lifetime. While an X-ray may be sufficient in some instances, others may necessitate a CT scan or MRI. Each ...

This initiative bridges the gap by developing advanced AI tools to analyze images from calcium-scoring computed tomography (CT) scans, a widely used diagnostic tool. The scans, which indicate how ...

A CT scan, or computed tomography scan, is a noninvasive medical imaging procedure that uses X-rays to create detailed pictures, typically used to see the inside of the body. A rare Kansas fossil ...

BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the inclusion of circulating ...

where 50% of positive scans or more are not due to residual lymphoma,” said Mark Roschewski, MD, Senior Clinician and the Clinical Director of the Lymphoid Malignancies Branch of the Center for ...